Control of gap junction formation in canine trachea by arachidonic acid metabolites
- 28 February 1986
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Cell Physiology
- Vol. 250 (3) , C495-C505
- https://doi.org/10.1152/ajpcell.1986.250.3.c495
Abstract
This study examined whether the synthesis of the metabolites of arachidonic acid (AA) was involved in gap junction formation by 4-aminopyridine (4-AP) treatment in vitro in canine trachealis. Studies were made of the effects on gap junction formation of putative inhibitors of the cyclooxygenase and of both this and the lipoxygenase pathway of AA metabolism and the direct effects of prostaglandins (PG) E2 and I2. The number of gap junctions of similar size was increased after brief exposure to 4-AP. After indomethacin (IDM), 4-AP treatment decreased the number of gap junctions but did not affect their size. Pretreatment with 5,8,11,14-eicosatetraynoic acid or nordihydroguiaretic acid, putative inhibitors of cyclooxygenase and lipoxygenase enzymes, inhibited both the 4-AP-induced increase and decrease in the number of gap junctions. FPL 55712, a putative antagonist of leukotriene C4, did not alter either the number or the size of gap junctions when added alone or in combination with IDM. AA alone increased the number of gap junctions, but after IDM, AA decreased the number of gap junctions compared with the controls. Incubation of trachealis strips in vitro for 30 min with PGE2 increased the number of gap junctions by about threefold along with an increase in the size of the gap junctions. Similar incubation with PGI2, however, increased the number of gap junctions by approximately 60% without any change in the size. In the course of some control experiments, an interaction between carbachol and alcohol was observed such that alcohol caused an IDM-sensitive relaxation of carbachol-induced contractions, which was not observed when serotonin was the contractile agent. These results strongly suggest that PGE2 and PGI2 increase the formation of gap junctions in canine trachealis and that these prostanoids are released by 4-AP treatment. Leukotrienes may also be inhibitory in the formation of gap junctions, but FPL 55712 did not affect either the increase or the decrease in gap junctions after 4-AP.This publication has 25 references indexed in Scilit:
- K+ Channels Gated by Voltage and IonsAnnual Review of Physiology, 1984
- Gap Junction Modulation in Rat Uterus. I. Effects of Estrogens on Myometrial and Serosal Cells 1Biology of Reproduction, 1984
- Aminopyridines: their pharmacological actions and potential clinical usesTrends in Pharmacological Sciences, 1982
- Effects of tetraethylammonium on potassium currents in a molluscan neurons.The Journal of general physiology, 1981
- 1-phenyl-3-pyrazolidone: An inhibitor of cyclo-oxygenase and lipoxygenase pathways in lung and plateletsProstaglandins, 1978
- Formation of gap junctions by treatment in vitro with potassium conductance blockers.The Journal of cell biology, 1978
- On the formation of thromboxane B2 and 12L-hydroxy-5, 8,10,14-eicosatetraenoic acid (12 ho-20:4) in tissues from the guinea pigBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1976
- Effect of tetraethylammonium on tonic airway smooth muscle: initiation of phasic electrical activityAmerican Journal of Physiology-Legacy Content, 1975
- Growth Kinetics in Cultured Epithelioid Cells and Phenotypic Expression of Blood Group HNature New Biology, 1973
- Inhibition of prostaglandin biosynthesis by eicosa-5,8,11,14-tetraynoic acidBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1970